Search results for "CYP1A2"

showing 6 items of 36 documents

Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems

1998

Abstract Sulfation is a common final step in the biotransformation of xenobiotics and is traditionally associated with inactivation. However, the sulfate group is electron-withdrawing and may be cleaved off heterolytically in some molecules leading to electrophilic cations which may form adducts with DNA and other important cellular structures. Since endogenous sulfotransferases do not appear to be expressed in indicator cells of standard mutagenicity tests, rat and human sulfotransferases have been stably expressed in his−Salmonella typhimurium strain TA1538 and Chinese hamster V79 cells. Using these recombinant indicator cells, sulfotransferase-dependent genotoxic activities were detected…

Salmonella typhimuriumHypoxanthine PhosphoribosyltransferaseSulfotransferaseToxicologyCricetulusSulfationBiotransformationCricetinaeBenzo(a)pyreneAnimalsHumansBiotransformationCarcinogenchemistry.chemical_classificationPyrenesMutagenicity TestsChemistryCYP1A2General MedicineRatsAmino acidEnzyme ActivationMetabolic pathwayBiochemistryCarcinogensHeterologous expressionSulfotransferasesSister Chromatid ExchangeMutagensChemico-Biological Interactions
researchProduct

Differential Effects of Fluvoxamine and Other Antidepressants on the Biotransformation of Melatonin

2001

Melatonin, the predominant product of the pineal gland, is involved in the maintenance of diurnal rhythms. Nocturnal blood concentrations of melatonin have been shown to be enhanced by fluvoxamine, but not by other serotonin reuptake inhibitors. Because fluvoxamine is an inhibitor of several cytochrome P450 (CYP) enzymes, the authors studied the biotransformation of melatonin and the effects of fluvoxamine on the metabolism of melatonin in vitro using human liver microsomes and recombinant human CYP isoenzymes. Melatonin was found to be almost exclusively metabolized by CYP1A2 to 6-hydroxymelatonin and N-acetylserotonin with a minimal contribution of CYP2C19. Both reactions were potently in…

Serotoninendocrine systemmedicine.medical_specialty10050 Institute of Pharmacology and Toxicology610 Medicine & healthFluvoxamineCitalopramPharmacologyImipramineMelatonin2738 Psychiatry and Mental HealthPineal glandTheophyllineCytochrome P-450 CYP1A2Internal medicineDesipraminemedicineHumans2736 Pharmacology (medical)Pharmacology (medical)Enzyme InhibitorsMelatoninFluoxetineChemistryPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologyFluvoxamineMicrosomes LiverAntidepressive Agents Second-Generation570 Life sciences; biologyReuptake inhibitorhormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

An in vitro tool to assess cytochrome P450 drug biotransformation-dependent cytotoxicity in engineered HepG2 cells generated by using adenoviral vect…

2011

Many adverse drug reactions leading to hepatotoxicity are caused by the cytochrome P450-dependent activation of non-toxic drugs or chemicals into reactive metabolites. To this end, adenoviruses were used as a tool to efficiently deliver specific CYP genes into cultured cells (i.e., human hepatoma cell line HepG2). Recombinant-defective adenoviral vectors encoding for genes CYP3A4 (Adv-CYP3A4), CYP2E1 (Adv-CYP2E1), CYP2A6 (Adv-CYP2A6) and CYP1A2 (Adv-CYP1A2) were used to confer specific CYP drug metabolic capabilities to HepG2 cells. Upgraded cells transiently expressed single specific cytochrome P450 enzymatic activities in terms of the number of the infecting virus particles used in their …

biologyCYP3A4Cell SurvivalGenetic VectorsCYP1A2Cytochrome P450Hep G2 CellsGeneral MedicineCYP2E1ToxicologyMolecular biologyAdenoviridaeTransduction (genetics)Cytochrome P-450 Enzyme SystemPharmaceutical PreparationsTransduction GeneticToxicity Tests Acutebiology.proteinHumansMTT assayViability assayCytotoxicityBiotransformationToxicology in Vitro
researchProduct

Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling

2021

Of the three enzymes in the human cytochrome P450 family 1, CYP1A2 is an important enzyme mediating metabolism of xenobiotics including drugs in the liver, while CYP1A1 and CYP1B1 are expressed in extrahepatic tissues. Currently used CYP substrates, such as 7-ethoxycoumarin and 7-ethoxyresorufin, are oxidized by all individual CYP1 forms. The main aim of this study was to find profluorescent coumarin substrates that are more selective for the individual CYP1 forms. Eleven 3-phenylcoumarin derivatives were synthetized, their enzyme kinetic parameters were determined, and their interactions in the active sites of CYP1 enzymes were analyzed by docking and molecular dynamic simulations. All cou…

entsyymitStereochemistryGeneral Chemical EngineeringCYP1B1Articlechemistry.chemical_compoundheterocyclic compoundsEnzyme kineticsQD1-999chemistry.chemical_classificationbiologysytokromitChemistryCYP1A2Substrate (chemistry)Active sitelääkeaineetGeneral Chemistryrespiratory systemCoumarinChemistrylääkkeetEnzymeDocking (molecular)biology.proteinbiolääketiedeACS Omega
researchProduct

Fruits and vegetables protect against the genotoxicity of heterocyclic aromatic amines activated by human xenobiotic-metabolizing enzymes expressed i…

2010

Heterocyclic aromatic amines (HAAs) can be formed during the cooking of meat and fish at elevated temperatures and are associated with an increased risk for cancer. On the other hand, epidemiological findings suggest that foods rich in fruits and vegetables can protect against cancer. In the present study three teas, two wines, and the juices of 15 fruits and 11 vegetables were investigated for their protective effect against the genotoxic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). To closely mimic the enzymatic activation of these HAAs in humans, genetically engineered V79 Chinese hamster fibroblasts were employed tha…

food.ingredientCytochrome P-450 CYP1A2 InhibitorsHealth Toxicology and Mutagenesismedicine.disease_causeGrapefruit juiceCell LineBeveragesCricetulusfoodCherry juiceHeterocyclic CompoundsCricetinaeVegetablesBotanyGeneticsmedicineAnimalsFood scienceAminescomic_books.seriesOrange juicebiologyChemistryCucumber juicefood and beveragesAntimutagenic Agentsbiology.organism_classificationfood.foodEnzyme assayEnzyme ActivationComet assayFruitRed currantcomic_booksbiology.proteinGenotoxicityMutagensMutation Research/Genetic Toxicology and Environmental Mutagenesis
researchProduct

Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.

2007

Abstract The suitability of liver grafts discarded for transplantation because of macrosteatosis for preparing human hepatocyte cultures for in vitro drug metabolism studies has been examined. Lower cell viability and yield of isolation procedure were obtained from fatty livers (>40% steatosis) with respect to normal tissue. Significant reductions in 7-ethoxycoumarin O-deethylation (ECOD) and testosterone oxidations were found in hepatocytes prepared from steatotic livers. The potential impact of lipid accumulation on P450 enzymes was studied in vitro by incubation of cultured hepatocytes with long chain free fatty acids (FFA). Treatment of cells with 0.25–3 mM FFA induced dose-dependent ac…

medicine.medical_specialtyCYP3A4CYP1A2General MedicineBiologyCYP2E1Fatty Acids NonesterifiedToxicologymedicine.diseaseTransplantationFatty LiverEndocrinologymedicine.anatomical_structureCytochrome P-450 Enzyme SystemInternal medicineHepatocytemedicineHepatocytesHumansTestosteroneViability assaySteatosisOxidation-ReductionDrug metabolismCells CulturedToxicology in vitro : an international journal published in association with BIBRA
researchProduct